Skip to main content
Log in

Adjust antimicrobial agent regimens in older patients to correct for changes in pharmacokinetics and to avoid adverse events

  • Drug Reactions and Interactions
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

Abstract

Treating infections with antimicrobial agents in older patients can be challenging. Physiological changes associated with aging can alter the pharmacokinetics of antimicrobial agents; dose adjustments may be required to provide effective and safe treatment. Additionally, the choice of antimicrobial agent can be limited by comorbidities and the use of other medications in these patients. It is vital to tailor the choice of antimicrobial agent and the dose to the clinical profile of the patient.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Schoevaerdts D, Sibille FX, Gavazzi G. Infections in the older population: what do we know? Aging Clin Exp Res. 2021;33(3):689–701.

    Article  PubMed  Google Scholar 

  2. Soraci L, Cherubini A, Paoletti L, et al. Safety and tolerability of antimicrobial agents in the older patient. Drugs Aging. 2023;40(6):499–526.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Budnitz DS, Lovegrove MC, Shehab N, et al. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med. 2011;365(21):2002–12.

    Article  CAS  PubMed  Google Scholar 

  4. Kaur U, Shubhra Chakrabarti S, Singh B, et al. A prospective observational pilot study of adverse drug reactions in patients admitted in the geriatric ward of a tertiary hospital in North India. Curr Pharmacogenom Pers Med. 2018;16(2):147–55.

    Article  CAS  Google Scholar 

  5. Olivier P, Bertrand L, Tubery M, et al. Hospitalizations because of adverse drug reactions in elderly patients admitted through the emergency department: a prospective survey. Drugs Aging. 2009;26(6):475–82.

    Article  PubMed  Google Scholar 

  6. Giarratano A, Green SE, Nicolau DP. Review of antimicrobial use and considerations in the elderly population. Clin Interv Aging. 2018;13:657–67.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Noreddin AM, Haynes V. Use of pharmacodynamic principles to optimise dosage regimens for antibacterial agents in the elderly. Drugs Aging. 2007;24(4):275–92.

    Article  CAS  PubMed  Google Scholar 

  8. Forbes GB, Reina JC. Adult lean body mass declines with age: some longitudinal observations. Metabolism. 1970;19(9):653–63.

    Article  CAS  PubMed  Google Scholar 

  9. Ulldemolins M, Roberts JA, Rello J, et al. The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patients. Clin Pharmacokinet. 2011;50(2):99–110.

    Article  CAS  PubMed  Google Scholar 

  10. Budingen FV, Gonzalez D, Tucker AN, et al. Relevance of liver failure for anti-infective agents: from pharmacokinetic alterations to dosage adjustments. Ther Adv Infect Dis. 2014;2(1):17–42.

    PubMed Central  Google Scholar 

  11. Mallappallil M, Friedman EA, Delano BG, et al. Chronic kidney disease in the elderly: evaluation and management. Clin Pract (Lond). 2014;11(5):525–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Bruck K, Stel VS, Gambaro G, et al. CKD prevalence varies across the European general population. J Am Soc Nephrol. 2016;27(7):2135–47.

    Article  PubMed  Google Scholar 

  13. Pereira JM, Paiva JA. Antimicrobial drug interactions in the critically ill patients. Curr Clin Pharmacol. 2013;8(1):25–38.

    CAS  PubMed  Google Scholar 

  14. Mazzei T. The difficulties of polytherapy: examples from antimicrobial chemotherapy. Intern Emerg Med. 2011;6(Suppl 1):103–9.

    Article  PubMed  Google Scholar 

  15. Levison ME, Levison JH. Pharmacokinetics and pharmacodynamics of antibacterial agents. Infect Dis Clin North Am. 2009;23(4):791–815.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Iwamoto M, Wenning LA, Nguyen BY, et al. Effects of omeprazole on plasma levels of raltegravir. Clin Infect Dis. 2009;48(4):489–92.

    Article  CAS  PubMed  Google Scholar 

  17. Weitschies W, Friedrich C, Wedemeyer RS, et al. Bioavailability of amoxicillin and clavulanic acid from extended release tablets depends on intragastric tablet deposition and gastric emptying. Eur J Pharm Biopharm. 2008;70(2):641–8.

    Article  CAS  PubMed  Google Scholar 

  18. Tremblay D, Dupront A, Ho C, et al. Pharmacokinetics of cefpodoxime in young and elderly volunteers after single doses. J Antimicrob Chemother. 1990;26(Suppl E):21–8.

    Article  CAS  PubMed  Google Scholar 

  19. Chutka DS, Evans JM, Fleming KC, et al. Symposium on geriatrics - part I: drug prescribing for elderly patients. Mayo Clin Proc. 1995;70(7):685–93.

    Article  CAS  PubMed  Google Scholar 

  20. Pea F, Viale P, Furlanut M. Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability. Clin Pharmacokinet. 2005;44(10):1009–34.

    Article  CAS  PubMed  Google Scholar 

  21. Faulkner CM, Cox HL, Williamson JC. Unique aspects of antimicrobial use in older adults. Clin Infect Dis. 2005;40(7):997–1004.

    Article  PubMed  Google Scholar 

  22. Schmucker DL. Liver function and phase I drug metabolism in the elderly: a paradox. Drugs Aging. 2001;18(11):837–51.

    Article  CAS  PubMed  Google Scholar 

  23. Stalam M, Kaye D. Antibiotic agents in the elderly. Infect Dis Clin North Am. 2000;14(2):357–69.

    Article  CAS  PubMed  Google Scholar 

  24. Trotman RL, Williamson JC, Shoemaker DM, et al. Antibiotic dosing in critically ill adult patients receiving continuous renal replacement therapy. Clin Infect Dis. 2005;41(8):1159–66.

    Article  CAS  PubMed  Google Scholar 

  25. Midao L, Giardini A, Menditto E, et al. Polypharmacy prevalence among older adults based on the survey of health, ageing and retirement in Europe. Arch Gerontol Geriatr. 2018;78:213–20.

    Article  PubMed  Google Scholar 

  26. Antoniou T, Gomes T, Juurlink DN, et al. Trimethoprim-sulfamethoxazole-induced hyperkalemia in patients receiving inhibitors of the renin-angiotensin system: a population-based study. Arch Intern Med. 2010;170(12):1045–9.

    Article  CAS  PubMed  Google Scholar 

  27. Baillargeon J, Holmes HM, Lin YL, et al. Concurrent use of warfarin and antibiotics and the risk of bleeding in older adults. Am J Med. 2012;125(2):183–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Chang SH, Chou IJ, Yeh YH, et al. Association between use of non-vitamin K oral anticoagulants with and without concurrent medications and risk of major bleeding in nonvalvular atrial fibrillation. JAMA. 2017;318(13):1250–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Lippi G, Favaloro EJ, Mattiuzzi C. Combined administration of antibiotics and direct oral anticoagulants: a renewed indication for laboratory monitoring? Semin Thromb Hemost. 2014;40(7):756–65.

    Article  CAS  PubMed  Google Scholar 

  30. Chinzowu T, Roy S, Nishtala PS. Risk of antimicrobial-associated organ injury among the older adults: a systematic review and meta-analysis. BMC Geriatr. 2021;21(1):617.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Lucena MI, Sanabria J, García-Cortes M, et al. Drug-induced liver injury in older people. Lancet Gastroenterol Hepatol. 2020;5(9):862–74.

    Article  PubMed  Google Scholar 

  32. Schliamser SE, Cars O, Norrby SR. Neurotoxicity of beta-lactam antibiotics: predisposing factors and pathogenesis. J Antimicrob Chemother. 1991;27(4):405–25.

    Article  CAS  PubMed  Google Scholar 

  33. Wooten JM. Pharmacotherapy considerations in elderly adults. South Med J. 2012;105(8):437–45.

    Article  PubMed  Google Scholar 

  34. Ramappa V, Aithal GP. Hepatotoxicity related to anti-tuberculosis drugs: mechanisms and management. J Clin Exp Hepatol. 2013;3(1):37–49.

    Article  PubMed  Google Scholar 

  35. Holmberg L, Boman G, Bottiger LE, et al. Adverse reactions to nitrofurantoin. Analysis of 921 reports. Am J Med. 1980;69(5):733–8.

    Article  CAS  PubMed  Google Scholar 

  36. Aspinall SL, Good CB, Jiang R, et al. Severe dysglycemia with the fluoroquinolones: a class effect? Clin Infect Dis. 2009;49(3):402–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Simon Fung.

Ethics declarations

Funding

The preparation of this review was not supported by any external funding.

Authorship and conflict of interest

Adis author S. Fung is a salaried employee of Adis International Ltd/Springer Nature and declares no relevant conflicts of interest. All authors contributed to this article and are responsible for its content.

Ethics approval, Consent to participate, Consent for publication, Availability of data and material, Code availability

Not applicable.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fung, S. Adjust antimicrobial agent regimens in older patients to correct for changes in pharmacokinetics and to avoid adverse events. Drugs Ther Perspect 40, 145–150 (2024). https://doi.org/10.1007/s40267-024-01065-w

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40267-024-01065-w

Navigation